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In this study, the components of Marburg virus nucleocapsid complex were determined, and interactions between the
compounds were investigated. Using salt dissociation of isolated virions, four proteins (NP, VP35, VP30, and L) remained
attached to the core complex. Same proteins were detected intracellularly to be localized in MBGV-induced inclusion bodies,
which are presumed to represent areas of nucleocapsid formation. To investigate interactions between the four proteins,
immunofluorescence analysis of coexpressed proteins was carried out. Complexes between NP-VP35 and NP-VP30 were
formed, which was demonstrated by redistribution of VP35 and VP30 into NP-induced inclusion bodies. Furthermore,
complexes between L and VP35 were detected by coimmunoprecipitation. Using deletion mutants of L, the binding site of
VP35 on L could be restricted to the N-terminal 530 amino-acid residues. Coexpression of NP, VP35, and L led to the
formation of a triple complex where VP35 linked NP and L. The detected complexes are presumed to represent the key
components of the MBGV transcription and replication machinery. © 1998 Academic Press
INTRODUCTION
Marburg virus (MBGV), together with Ebola virus
(EBOV), constitutes the family of filoviruses, which be-
longs to the order Mononegavirales. MBGV, like EBOV,
causes severe hemorrhagic diseases in monkeys and
humans resulting in high fatality rates (Martini and Sie-
gert, 1971). Genomic RNA of MBGV is 19,108 nucleotides
in length (for reference, see EMBL Nucleotide Sequence
Database, accession number Z12132 and Bukreyev et al.,
1995) and is transcribed into monocistronic mRNA spe-
cies (Feldmann et al., 1992; Mu¨hlberger et al., 1996)
encoding seven viral structural proteins. These are (ac-
cording to gene order): the nucleoprotein (NP, Sanchez et
al., 1992; Becker et al., 1994), viral proteins VP35 and
VP40, a single surface protein (GP) inserted in the viral
membrane (Will et al., 1993; Becker et al., 1996), viral
proteins VP30 and VP24, and the putative polymerase (L;
Mu¨hlberger et al., 1992). Very little is known about repli-
cation and transcription of filoviruses. Neither the pro-
teins involved in this process are defined nor, in the case
of MBGV, the exact composition of the nucleocapsid
complex, which is presumed to contain the proteins
involved in RNA synthesis. So far the actual view of
MBGV replication and transcription can only be inferred
from data obtained with paramyxo- and rhabdoviruses. It
is thought that the template for RNA synthesis is the
ribonucleoprotein complex consisting of viral RNA en-
capsidated by the product of the first gene, NP. The
polymerase function is presumed to be carried out by the
last gene product, the L protein (Mu¨hlberger et al., 1992),
together with a protein cofactor, which might either be
represented by the second gene product, VP35, or the
fifth gene product, VP30. For EBOV it was shown that
both proteins were found to be associated with the core
complex of isolated EBOV virions (Elliott et al., 1985). The
existence of four nucleocapsid proteins is unusual and
has yet only be described for respiratory syncytial virus
(RSV, Garcia et al., 1993; Collins et al., 1996). Understand-
ing the interplay of the various components of the pro-
cess of replication and transcription of MBGV will re-
quire, as a first step, knowledge about identity of nucleo-
capsid proteins and interactions of the nucleocapsid
proteins with each other and the genomic RNA. To this
end, protein composition of the nucleocapsid complex of
MBGV was investigated. Subsequently, interaction of the
identified nucleocapsid proteins was investigated using
coimmunoprecipitation of in vitro translated proteins and
indirect immunofluorescence analyses of recombinant
proteins expressed with the help of the vaccinia virus T7
expression system. Results suggest interactions be-
tween NP/VP35, VP35/L, NP/VP35/L, and NP/VP30.
RESULTS
Composition of the nucleocapsid complex
To investigate which of the MBGV proteins were as-
sociated with the nucleocapsid complex, isolated virions
from MBGV-infected C1008 cells were treated with in-
creasing concentrations of NaCl in the presence or ab-
sence of 0.1% Triton X-100. Interaction of proteins in-
volved in the formation of the nucleocapsid complex is
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relatively strong and therefore resists high-salt treat-
ment, whereas matrix and surface proteins are released.
Intact nucleocapsids, separated from viral membrane
and matrix proteins, could then be pelleted through a
sucrose cushion, whereas solubilized proteins would be
found in the supernatant as it has been shown for EBOV
(Elliott et al., 1985). When virions were incubated with 150
mM NaCl in the absence of Triton X-100, none of the viral
proteins could be detected in the supernatant (Fig. 1). At
the same salt concentration in the presence of Triton
X-100, GP disappeared from the virion. However, GP
could not be detected in the supernatant probably be-
cause TCA precipitation was not quantitative, and glyco-
proteins in general are not very well detected by Coo-
massie blue staining. In addition to GP, small amounts of
VP40 and VP24 were released at 150 mM NaCl and
found in the supernatant. Increase of NaCl concentration
to 300 mM released VP24 almost completely and the
majority of VP40 as well as small amounts of VP35. At 1
M NaCl, NP, VP35, VP30, and L were still present in the
particulate fraction and traces of VP40 were visible. It is
therefore concluded that NP, VP35, VP30, and L consti-
tute the nucleocapsid complex. Release of VP40 and
VP24 with increasing salt concentrations supports the
view that these proteins are located in the matrix space
between nucleocapsid complex and viral membrane.
Traces of VP40, which still could be detected in nucleo-
capsids even after the highest NaCl concentration used,
reflected the high amount of this protein in the virion
rather than specific interaction with the nucleocapsid.
To determine the intracellular distribution of nucleo-
capsid proteins, immunofluorescence analyses of
MBGV-infected cells were performed. In Fig. 2, it is
shown that NP is associated with the typical inclusion
bodies which are related to MBGV infection (Figs. 2A,
2C, and 2E; Becker et al., 1992). Also VP35 and VP30
were found within inclusion bodies and colocalized
with NP (Figs. 2B and 2D). Detection of L was not
possible because available antiserum was not suit-
able for immunofluorescence analysis. When localiza-
tion of the presumed matrix protein VP40 was inves-
tigated, a clearly different staining pattern emerged
(Fig. 2F). Detected distribution of VP40 is rather con-
sistent with a plasma membrane association of this
protein. VP40 could not be found inside the inclusion
bodies. Intracellular localization of GP in MBGV-in-
fected cells, determined previously, revealed GP at the
plasma membrane and in the endoplasmic reticulum,
but it was not involved in the formation of inclu-
sion bodies (Becker et al., 1996). Mock-infected cells
stained with the same antibodies did not show a
specific signal. Taken together, immunofluorescence
analysis showed NP, VP35, and VP30 to be colocalized
inside the inclusion bodies and clearly separated from
the matrix protein VP40 and the surface protein GP.
Thus analysis of intracellular distribution of viral struc-
tural proteins supported the concept that NP, VP35,
VP30, and L probably represent the protein constitu-
ents of the nucleocapsid complex of MBGV.
Recombinant expression of nucleocapsid proteins
To investigate interactions between nucleocapsid
components, proteins were expressed by the vaccinia
virus T7 expression system (Fuerst et al., 1986). HeLa
cells were infected with the recombinant vaccinia virus
vTF7–3 and subsequently transfected with plasmids en-
coding either NP, VP35, VP30, and L under the control of
the T7 RNA polymerase promoter. To examine protein
expression, cells were labeled with [35S]methione, lyzed,
and analyzed by immunoprecipitation using specific an-
tisera against VP35, NP, and VP30 (Fig. 3, lanes 1, 3, and
4). All proteins migrated with the expected velocity. L
protein, however, could only be visualized after a Flag
epitope (Hopp et al., 1988) was fused to the N terminus
of the protein. In vitro translation of L and LFlag revealed
that LFlag was much better expressed than untagged L
(data not shown) probably because the start codon was
located in a better context regarding the rules found by
Kozak (1986). LFlag was also expressed using the vac-
cinia virus T7 expression system and precipitated with a
monoclonal antibody against the Flag epitope. Using this
method, it was possible to detect for the first time re-
combinant expression of L. As can be seen in Fig. 3, lane
2, LFlag migrated in SDS–PAGE at approximately 220 kDa,
which was faster than expected since calculated Mr was
267 kDa. In viral structural proteins L of MBGV also
FIG. 1. Salt dissociation of isolated virions. Isolated virions were
treated with increasing concentrations of NaCl in the presence (1)
or absence (2) of Triton X-100. Treated virions were centrifuged
through a 20% sucrose cushion, and aliquots of pellets (P) and
supernatants (S) were separated by SDS–PAGE (12% polyacryl-
amide, 2.5 M urea). Gels were fixed and subsequently stained with
Coomassie blue. Positions of the structural proteins are given at
both sides of the gel.
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FIG. 2. Immunofluorescence analysis of MBGV-infected cells. Subconfluent Vero cells were infected with MBGV. Cells (24 h p.i.) were washed with
PBS and fixed. Cells were then probed with monospecific or monoclonal antibodies against MBGV structural proteins. Secondary antibodies were
either coupled to FITC or Cy3. (A and B) Colocalization of NP and VP30. Double immunofluorescence with a monoclonal anti-NP in (A) and guinea
pig anti-VP30 serum in (B). (C and D) Colocalization of NP and VP35. Double immunofluorescence with a guinea pig anti-NP serum in (C) and a
monoclonal anti-VP35 antibody in (D). (E and F) Localization of NP and VP40. Double immunofluorescence with a guinea pig anti-NP serum in (E) and
a monoclonal anti-VP40 antibody in (F).
408 BECKER ET AL.
migrated at 220 kDa (Fig. 1). Differences between appar-
ent Mr and calculated Mr of L has also been observed for
RSV (Huang et al., 1985). L, NP, and VP30 seemed to be
slightly proteolytically degraded which is reflected by the
smaller protein bands in the respective lanes (Fig. 3,
2–4).
Immunofluorescence analyses of nucleocapsid
proteins
To investigate intracellular distribution of recombinant
proteins, HeLa cells expressing either of the nucleocap-
sid proteins were investigated by immunofluorescence
analysis. Interestingly, localization of VP35 and VP30 was
altered when expressed without the context of other viral
proteins. Instead of being concentrated in inclusion bod-
ies, as in MBGV-infected cells, VP35 and VP30 were
homogeneously distributed throughout the cytoplasm
(Figs. 4B and 4C). The staining pattern observed for LFlag
was homogeneous as well (Fig. 4D). However, large
cytosolic aggregates were found in cells expressing NP
(Fig. 4A). These aggregates resembled the inclusion
bodies detected in MBGV-infected cells. In all immuno-
fluorescence analyses shown in this paper, mock-
infected and vTF7–3-infected cells were included as con-
trol. No specific signals were observed in these cells
(data not shown).
Taking advantage of this unique distribution of NP, it
was presumed that interaction of NP with other proteins
might result in alterations of the original staining pattern.
Either NP should no longer be aggregated or its binding
partner should be directed into the NP-induced granules.
Using the vaccinia virus T7 expression system, NP was
coexpressed in HeLa cells together with VP35, VP30, or
L. Subsequently immunofluorescence analyses of the
cells were carried out (Fig. 5). When NP was expressed
in the presence of VP35, the latter was no longer homo-
geneously distributed. VP35 was detected in cytosolic
aggregates and completely colocalized with NP, sug-
gesting an interaction between NP and VP35 (Figs. 5A
and 5B). A similar effect was detected after coexpression
of NP and VP30 (Figs. 5C and 5D). The homogeneous
appearance of VP30 without NP (shown in Fig. 4C) was
replaced by a staining pattern where VP30 was redistrib-
uted in the NP-induced inclusion bodies (Figs. 5C and
5D). However, though VP30 was detected in aggregates
with NP, traces of VP30 were also found outside of these
structures. No interaction was observed when NP was
coexpressed with L, VP40, or GP (data not shown).
Coimmunoprecipitation
To further analyze the interaction between NP/VP35
and NP/VP30, nucleocapsid proteins were cotranslated
in vitro and immunoprecipitated with monospecific anti-
bodies. In Fig. 6A, it is shown that antibodies against NP
while precipitating NP also cosedimented VP35. Vice
versa, precipitation of VP35 sedimented the coexpressed
NP. Neither the antibody against NP precipitated VP35
nor the antibody against VP35 precipitated NP when both
proteins were expressed alone (Fig. 6A). Coexpression
of NP and VP30 with subsequent immunoprecipitation
revealed that antibodies against VP30 cosedimented NP
(Fig. 6B). However, antibodies against NP failed to co-
precipitate VP30 for hitherto unknown reasons. Similar
phenomenon was found by Garcia et al. (1993) for N–M2
interactions of respiratory syncytial virus. Only the an-
ti-M2 antibodies were able to cosediment N with M2.
Anti-N antibodies precipitated only N when both proteins
were cotranslated. Although a definitive explanation for
this result is missing, it is assumed that one of the
antibody binding sites is in close proximity to the inter-
action domain for VP30 leading to competition between
antibody binding and protein interaction. Figure 6 shows
again the tendency of NP and VP30 to proteolytical deg-
radation (see Fig. 3).
Finally, it was checked whether complex formation
between coexpressed L and VP35 takes place. However,
it was not possible to express LFlag in suitable amounts
by in vitro translation. To overcome this problem, a Flag-
tagged C-terminal deletion mutant of L was constructed
(L530, spanning the N terminus up to aa 530) which could
be successfully translated in vitro. After coexpression of
VP35 and L530, anti-Flag antibody precipitated not only
L530 but also VP35 (Fig. 7A). Likewise, anti-VP35 antibody
coimmunoprecipitated L530. It was therefore concluded
that VP35 interacts with L via the N terminus of L. To
FIG. 3. Immunoprecipitation of recombinant MBGV nucleocapsid
proteins. HeLa cells (1 3 106) were infected with vTF7–3 as described
and subsequently transfected with 1 mg of plasmids encoding either
NP, VP35, VP30, or LFlag. Cells (18 h p.i.) were labeled with [
35S]promix
and lyzed 1 h later. Following antibodies were used for immunopre-
cipitation: A monoclonal anti-VP35 antibody (lane 1), a monoclonal
anti-Flag antibody (lane 2), a monoclonal anti-NP antibody (lane 3), or
a guinea pig anti-VP30 serum (lane 4). Positions of structural proteins
are given at right.
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further narrow down the binding site for VP35 on L, two
additional deletion mutants of L (L120 and L309) were
constructed with increasing C-terminal deletions (Fig. 7,
top). Coexpression of the mutants together with VP35
revealed that the two smaller fragments of L did not
interact with VP35 (Figs. 7B and 7C). Thus it is concluded
that interaction domain for VP35 on L is located in the
amino-terminal 530 aa residues. The region between aa
309 and 530 is essential for binding.
Complex formation between L-VP35-NP
Since complex formation was detected for NP/VP35
and VP35/L, it was further examined whether complexes
could be formed between NP, VP35, and L. Using the
vaccinia virus T7 expression system, all three proteins
were coexpressed in HeLa cells. The cells were then
probed for distribution of LFlag using immunofluores-
cence analysis. Whereas expression of L alone or coex-
pression with NP revealed a rather homogeneous stain-
ing pattern of L (Fig. 4D, data not shown), coexpression
together with NP and VP35 led to a redistribution of L
which was found in the NP-induced inclusion bodies
(Figs. 8A and 8B). This result suggested the formation of
a trimeric complex between NP, VP35, and L. The same
experiment was carried out replacing VP35 with VP30
(Fig. 8C). However, coexpression with NP and VP30 did
not result in redistribution of L. Subsequently, the above-
mentioned mutants of L were tested for their ability to
form the trimeric complex. Only L530 was detected in the
inclusion bodies built by NP and VP35 (Fig. 8E). Distri-
bution of the smaller mutants were not influenced by the
simultaneous expression of NP and VP35 (Figs. 8F and
8G). L309 itself had a tendency to self-aggregate, but
these aggregates did not colocalize with NP in inclusion
FIG. 4. Distribution of singly expressed nucleocapsid proteins in HeLa cells. HeLa cells (1 3 106) on glass coverslides were infected with vTF7–3
and subsequently transfected with 1 mg of plasmids encoding either NP, VP35, VP30, or LFlag. Cells (8 h p.i.) were washed, fixed, and probed with
the same antibodies as described under Fig. 2 and an anti-Flag antibody. Used antibodies are given at the top of the panels.
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bodies. This experiment underscored the previous re-
sults (Fig. 7) showing aa region between 309 and 530 to
be critical for interaction with VP35. Since binding of L to
VP35 was the prerequisite for the formation of the trim-
eric complex, it is evident that VP35 mediates binding
between L and NP.
Taken together the data shown here revealed that
presence of NP is the prerequisite for formation of inclu-
sion body-like structures. Localization of the other nu-
cleocapsid proteins in these structures is always depen-
dent on direct or indirect binding to NP. Following inter-
actions between proteins of the nucleocapsid complex of
MBGV have been observed: NP is able to form com-
plexes with VP35 and VP30. Complex formation was also
detected between L and VP35. Additionally, a trimeric
complex was observed among NP, VP35, and L with
VP35 connecting L and NP.
DISCUSSION
In the present study, protein components of the nu-
cleocapsid complex of MBGV were investigated and in-
teractions between these proteins were determined.
Since it is known that proteins constituting the nucleo-
capsid complex are the key components for transcription
and replication of viral RNA, these experiments repre-
sent the first step to gaining further insight into the
central part of filovirus life cycle.
We used two different approaches to determine the
protein components of MBGV nucleocapsid complex.
First, we investigated isolated virions by salt dissoci-
ation in the presence of Triton X-100. Compared with
the closely related EBOV, the detergent concentration
used for removal of viral membrane needed to be
considerably lower (Elliott et al., 1985). Using 1% NP-
FIG. 5. Immunofluorescence analyses of VP35 and VP30 coexpressed with NP. HeLa cells were infected and transfected as described in Fig. 4,
except that plasmids encoding NP and VP35 or NP and VP30 were cotransfected. (A and B) Coexpression of NP and VP35. (A) Cells were stained
with anti-NP antibody. (B) Same cells were probed with anti-VP35 antibody. (C and D) Coexpression of NP and VP30. (C) Cells were stained with
anti-NP antibody. (D) Same cells were probed with anti-VP30 antibody.
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40, as with EBOV, completely dissociated the nucleo-
capsid (data not shown), indicating that MBGV nucleo-
capsids were more fragile than EBOV nucleocapsids.
We found NP, VP35, VP30, and L to be attached tightly
to the core complex; a result that is comparable to that
in EBOV where the analogous proteins were deter-
mined to constitute the nucleocapsid complex. Three
of these proteins (NP, VP35, and VP30) were also
found to be colocalized in intracellular inclusion bod-
ies in MBGV-infected cells. Inclusion bodies are
thought to be light microscopic correlates of cytoplas-
mic sites where nucleocapsid formation and deposi-
tion in MBGV-infected cells occurred (Geisbert et al.,
1995; Ryabchikova et al., 1996). It is presumed that L is
also located inside the inclusion bodies since L is
strongly associated with the core structure in isolated
virions. It was further investigated whether specific
interactions of the four proteins led to assembly of the
nucleocapsid. Coexpression of nucleocapsid proteins
revealed interactions among NP-VP35, NP-VP30,
VP35-L, and NP-VP35-L. The presence of NP was crit-
ical for localization of VP35 and VP30 into granules
resembling inclusion bodies in MBGV-infected cells.
Interaction between NP and VP35 (first and second
gene product) parallels interaction between N (NP)
and P of paramyxo-, rhabdo-, and bornaviruses (Davis
et al., 1986; Masters and Banerjee, 1988; Ryan and
Portner, 1990; Huber et al., 1991; Horikami et al., 1992;
Schwemmle et al., 1998). When distribution of coex-
pressed N (NP) and P of measles virus, respiratory
syncytial virus, human parainfluenza virus, and rabies
virus was investigated by immunofluorescence, forma-
tion of inclusion bodies was detected as it was shown
for coexpressed VP35 and NP of MBGV (Chenik et al.,
1994; Garcia-Barreno et al., 1996; Nishio et al., 1996;
Spehner et al., 1997).
Since expression of NP alone was sufficient to pro-
duce granule-like structures, it is unclear whether gran-
ules formed by coexpression of NP and VP35 are iden-
tical to those formed by NP alone. Concerning aggrega-
tion of N or NP of other Mononegavirales, proteins
behave differently when expressed alone. NP of human
parainfluenza virus and N of rabies virus are homoge-
neously distributed, whereas NP of measles virus forms
inclusion body-like structures (Spehner et al., 1991;
Chenik et al., 1994; Bankamp et al., 1996; Nishio et al.,
1996). For Sendai virus, aggregation of singly expressed
NP is regarded as illegitimate assembly which is pre-
vented by interaction with P (Curran et al., 1995).
Interaction of nucleocapsid proteins is not only essen-
tial for assembly of the core structure but has also
specific functions in viral replication and transcription.
Best investigated among Mononegavirales are func-
tional complexes between P–L and NP–P. As far as has
been investigated, these complexes were found with all
paramyxo- and rhabdoviruses.
The complex between P and L represents the active
viral polymerase (Banerjee and Barik, 1992; Horikami
et al., 1992) with P as putative cofactor for the multi-
functional L. The binding site for P is located in the
N-terminal half of L proteins of Sendai virus and sim-
ian virus 5 (Parks, 1994; Chandriaka et al., 1995). With
FIG. 6. Coimmunoprecipitation of NP-VP35 and NP-VP30. NP and VP35 or NP and VP30 were cotranslated using a rabbit reticulocyte lysate. Lysates
were immunoprecipitated using an anti-NP, anti-VP35, or anti VP30 antibody as indicated. (A) Coexpression of NP and VP35. (B) Coexpression of NP
together with VP30. To the right of each panel positions of the proteins are given.
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measles virus, the binding site has been cut down to
the first 408 aa of L (Horikami et al., 1994). The present
study shows that the binding site of VP35 on L was
located at the N terminus between aa 1 and 530; L
mutants containing only the N-terminal 309 aa did not
bind to VP35. Thus the close relationship between
filoviruses and paramyxoviruses is underlined. Inter-
estingly, the binding domain for P on the L protein of
vesicular stomatitis and rabies virus, both rhabdovi-
ruses, resides in the C terminus of L (Canter and
Perrault, 1996; Chenik et al., 1998).
Functions of NP–P interactions are more complex.
Best investigated is the NP–P complex of Sendai virus.
Interaction between nonaggregated NP (NP0) and P is
thought to keep NP functional by preventing illegitimate
self-aggregation. NP0–P might then deliver NP to the
nascent RNA chain during replication of viral RNA (Cur-
ran et al., 1995). NP–NP interaction is subsequently
needed to extend encapsidation. Finally, active polymer-
ase (P–L) binds to NP-encapsidated RNA via another
NP–P interaction (NPNC–P) which could be differentiated
from the NP0–P complex. Our results clearly showed
binding of NP and VP35 of MBGV. Further investigations
must reveal whether complex formation between differ-
ent forms of NP (nonaggregated and nucleocapsid-as-
sociated) and VP35 occur.
Trimeric complexes among NP, VP35, and L were
detected by immunofluorescence analysis, showing L
to be involved in inclusion body formation in the pres-
ence of VP35. The determined N-terminal binding site
for VP35 (aa 1–530) was also sufficient for formation of
the trimeric complex. Thus VP35 turned out to be the
link between L and NP. The function of the trimeric
complex is not clear. It might reflect binding of the
polymerase complex (L-VP35) to encapsidated RNA
since NP of MBGV is presumed to be the RNA-encap-
sidating protein.
Most parymyxo- and rhabdoviruses contain three
nucleocapsid proteins responsible for synthesis of vi-
ral RNA. Pneumoviruses, however, have an additional
protein (22K or M2) associated with the nucleocapsid
complex which was shown to be involved in the tran-
scription process (Garcia et al., 1993; Collins et al.,
1996). VP30 is the fourth nucleocapsid protein of
MBGV. The position of VP30 gene in the genome is not
typical for a nucleocapsid protein and also is different
FIG. 7. Coimmunoprecipitation of L mutants and VP35. Flag-tagged mutants of L were cotranslated with VP35 using a rabbit reticulocyte lysate. (A)
Coimmunoprecipitation of L530 with VP35. (B) Coimmunoprecipitation of L309 and VP35. (C) Coimmunoprecipitation of L120 and VP35. Top: Schematic
representation of L mutants. Position of the proteins is depicted to the right of each panel.
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from the M2 gene of respiratory syncytial virus. How-
ever, as M2, which builds complexes with N of respi-
ratory syncytial virus, VP30 was found to build com-
plexes with NP. Both, M2 and VP30 are located in the
inclusion bodies of infected cells. Unlike M2, VP30 is
tightly associated with the core complex of MBGV.
However, the detergent concentration used to define
the location of M2 in the virion was considerably
higher than in the present study (Huang et al., 1985).
Therefore, the salt dissociation experiments can only
partly be compared. The role of VP30 and the NP-VP30
complex for replication or transcription is currently
under investigation. The data presented here under-
scores the close relationship between filoviruses and
pneumoviruses (Sanchez et al., 1992).
MATERIALS AND METHODS
Cells and viruses
The Musoke strain of MBGV isolated 1980 in Kenya
(Smith et al., 1982) was propagated in E6 or Vero cells.
The cells were infected with MBGV at a multiplicity of
infection (m.o.i.) of 1022 plaque forming units (p.f.u.) per
cell. Purification of viral particles and preparation of viral
antigen were performed as described previously (Mu¨hl-
berger et al., 1992). The final pellet of purified virus
particles was resuspended in TNE (10 mM Tris-HCl, pH
7.4; 0.15 M NaCl; and 2 mM EDTA). Monolayer cultures of
HeLa cells were used for all experiments with recombi-
nant vaccinia virus. Cells were grown in six-well plates (7
cm2) using Dulbecco’s medium containing 10% FCS (fetal
FIG. 8. Immunofluorescence analysis of LFLAG and L fragments coexpressed with NP in the presence of VP35 or VP30. HeLa cells were infected
and transfected as described under Fig. 4 and assayed by immunofluorescence analysis. Following combinations of plasmids were used: (A and B)
NP, VP35, and LFlag. (C and D) NP, VP30, and L Flag. (E) NP, VP35, and L530. (F) NP, VP35, and L309. (G) NP, VP35, and L120. Cells were probed either
with anti-NP antibody (A and C) or anti-Flag antibody (B, D-G).
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calf serum). The recombinant vaccinia virus containing
the T7 RNA polymerase gene (vTF7–3; Fuerst et al., 1986)
was grown and titered by plaque assay in HeLa cells.
Plasmids and molecular cloning
The plasmids pT/NP, pT/VP30, pT/VP35, and pT/L con-
tain the ORF of NP, VP30, VP35, or L gene of MBGV under
the control of the T7 RNA polymerase promoter. The pT/
LFlag plasmid used in this study was constructed by attach-
ing the Flag epitope (Hopp et al., 1988) to the 59 end of the
L gene (mRNA sense) in pT/L. The oligonucleotides
59-AGGATGGACTACAAGGACGACGATGACAAGCCTATG-39
and 59-AGGCTTGTCATCGTCGTCCTTGTAGTCCATCCT-39
encoding the Flag epitope (underlined) were hybridized by
incubation for 20 min in annealing buffer [stock concentra-
tion (73): 1 M Tris-HCl, pH 7.6; 100 mM MgCl2; and 160 mM
DTT] at 37°C followed by 10 min at room temperature. Each
primer (360 pmol) was used in a final volume of 20 ml. The
resulting double-strand Flag epitope containing a blunt end
(59 end), and a SfiI (39 end) restriction site (italics) was
purified by ethanol precipitation and cloned into the SmaI/
SfiI digested pT/L plasmid. The resulting pT/LFlag plasmid
was verified by sequencing across the gene junctions.
Three C-terminal deletions of L were generated (Fig.
7). L120 was generated by cleavage of pT/LFlag with
BglII and StuI, subsequent fill in of the BglII site with
Klenow, and religation of the blunt ends. The resulting
mutant had a coding capacity for the N-terminal 120aa.
Two additional aa were encoded by the vector (P-N-
COOH). For L309, vector pT/LFlag was cut with SalI and
AccI and religated after Klenow fill in resulting in an
ORF coding for the 309 N-terminal aa of L. Five addi-
tional aa were encoded by the vector (R-R-S-G-C-
COOH). L530 was generated while cloning pT/LFlag.
After passage through Escherichia coli, nucleotide
1589 of the L gene was deleted, thus creating a stop
codon immediately downstream the deletion. The re-
sulting ORF had a coding capacity of 530 aa. All
mutants were verified by sequencing.
In vitro transcription/translation
Reaction was carried out using the TNT coupled in
vitro transcription/translation kit according to the proto-
col of the supplier (Promega). For single expression of
proteins 1 mg of plasmid DNA was used.
Isolation of nucleocapsids from purified virions
Isolated virions (50 ml) were resuspended in 2 ml TNE
supplemented with different amounts of NaCl (final con-
centration: 150 mM, 300 mM, and 1 M) and 0.1% Triton
X-100. Virions were incubated for 12 min at 4°C and
subsequently centrifuged in a SW28 rotor (Beckmann)
through a cushion of 20% sucrose at 25,000 rpm for 2 h
at 4°C. An aliquot of the supernatant was removed and
used for trichloroacetic acid (TCA) precipitation of pro-FIG. 8—Continued
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teins. Pellets of the sucrose cushion and TCA precipita-
tion were resuspended in 50 ml TNE. For SDS–PAGE,
12.5 ml of the samples were supplied with 12.5 ml SDS
sample buffer (20% glycerol; 0.125 M Tris-HCl, pH 8.8; 4%
SDS; 10% b-mercaptoethanol; 0.05% bromphenal blue)
and boiled for 5 min. Proteins were then separated on
SDS–PAGE.
Coimmunoprecipitation with in vitro translated
proteins
In vitro translated proteins (2 ml) were suspended in
500 ml CoIP buffer (150 mM KCl; 10 mM Tris-HCl, pH 8.0;
0.1% NP-40; 25 mM jodoacetamide; 5% trasylol; 2 mM
PMSF; and 3% BSA; Raker et al., 1996) and centrifuged
for 30 min at 15,000 g, 4°C. Preclearing was performed
by addition of 20 ml protein A-sepharose (PAS) for 1 h at
4°C. Thereafter samples were centrifuged (15,000 g, 1
min), and antibodies were added to the supernatant as
indicated in the legends of the figures. (a NP: 1.25 ml,
aVP35: 0.1 ml, aVP30: 4 ml, aFlag: 2 ml) After incubation
for 1.5 h at 4°C, 20 ml PAS was added, and incubation
was continued for 1.5 h at 4°C. Subsequently, samples
were centrifuged for 1 min at 15,000 g and washed three
times with CoIP buffer and once with CoIP buffer without
BSA. After addition of 25 ml sample buffer, samples were
boiled and separated by SDS–PAGE.
Expression of recombinant MBGV proteins
Transient expression of MBGV NP, VP30, VP35, and
LFlag proteins was based on the vaccinia virus T7 expres-
sion system, which was first described by Fuerst et al.
(1986). Subconfluent monolayers of HeLa cells in six-well
plates were infected with vaccinia virus vTF7–3 at an
m.o.i. of approximately 5 p.f.u./cell at 37°C for 1 h. Sub-
sequently, cells were transfected with the different plas-
mids (1 mg each) using 5 ml Lipofectin (Gibco) in a total
volume of 2 ml Dulbecco’s medium per well (7 cm2)
according to the instructions of the supplier. Transfected
cells were then used for immunoprecipitation or immu-
nofluorescence analyses.
Immunoprecipitation
Experiments were performed as described previously
by Becker et al. (1996). Same antibodies and dilutions
were used as decribed under coimmunoprecipitation
(see above).
Immunofluorescence analyses
Vaccinia virus system. HeLa cells were cultured on
glass coverslides to 50% confluence and infected and
transfected as described above. Eight hours after trans-
fection cells were fixed with ice-cold methanol/acetone
(1:1) at 220°C for 5 min, washed with PBS, incubated
with 100 mM glycine for 10 min, washed with PBS, and
incubated for 1 h with the respective antibodies as indi-
cated in the figure legends. Subsequently, cells were
washed three times with PBS and stained with FITC-
conjugated anti-rabbit IgG (diluted 1:75 in PBS/3% BSA)
or anti-guinea pig IgG (diluted 1:50 in PBS/3% BSA) or
with Cy3-conjugated anti-mouse IgG (diluted 1:100 in
PBS/3% BSA) for 1 h at room temperature. Finally, cells
were washed three times with PBS, dipped into dH2O,
covered with mounting medium, and examined using a
fluorescence microscope (Axiomat, Zeiss).
MBGV infection. Monolayers of 5 3 105 (7 cm2) Vero
cells grown on glass coverslides were infected with
MBGV at an m.o.i. of 1 p.f.u./cell. After 24 h at 37°C,
monolayers were rinsed twice with PBS and fixed with
4% paraformaldehyde in PBS (RT, 20 min), followed by
acetone/methanol (1:1) treatment (220°C, 3 min). Immu-
nofluorescence analysis was further carried out as de-
scribed above. To prevent cross-reactivity between sec-
ondary antibodies during double immunofluorescence,
diluted FITC-coupled anti-guinea pig antibodies were
preincubated with 1 volume mouse Ig-agarose (Sigma),
and Cy3-coupled anti-mouse antibodies were preincu-
bated with agarose-coupled guinea pig immunoglobu-
lins (Sigma). Preadsorption proceeded for 1 h on ice.
After this period, samples were shortly spun down and
supernatants were combined and used as secondary
antibodies. Dilutions of the primary antibodies were as
follows: guinea pig anti-NP serum, 1:100; guinea pig
anti-VP30 serum, 1:100; monoclonal anti-NP antibody,
1:25; monoclonal anti-VP35 antibody, 1:1000; monoclonal
anti-VP40 antibody, 1:1000; and monoclonal anti-Flag an-
tibody, 1:100. Anti-VP30 antiserum was a generous gift of
Dr. H. Feldmann; anti-VP35 and anti-VP40 monoclonal
antibodies were a generous gift of Dr. A. Sanchez.
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